Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KINECT: Valbenazine in Tardive Dyskinesia
NCT01688037Phase 2Completed
- Sponsor
- Neurocrine Biosciences
- Start
- Sep 2012
- Primary completion
- Sep 2013
- Modality
- Orthosteric Ligands, Prodrugs/Conditional Activator Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of valbenazine in tardive dyskinesia (TD), sponsored by Neurocrine Biosciences. Started Sep 2012; status: completed.
02
Drugs
valbenazine
03
Conditions
tardive dyskinesia (TD)
Beyond the preview
Go deeper on NCT01688037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01688037.